New study reveals best way to spot dangerous colon growths
NCT ID NCT01521091
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared three methods used during colonoscopy to predict whether colorectal growths are cancerous: narrow band imaging (NBI), indigo carmine staining, and acetic acid staining. Researchers studied 565 patients with at least one lesion 6mm or larger. The goal was to see which method most accurately identifies invasive cancer. Results suggest NBI may be the best first choice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
narrow band imaging, indigo carmine, and acetic acid staining
What this could lead to
If successful, this could help doctors choose the best method to accurately diagnose colorectal lesions during colonoscopy, potentially reducing unnecessary biopsies.
What could go wrong
This is a completed diagnostic accuracy study, not a treatment trial. Results may not apply to all patients or settings, and the methods require specialized equipment and training.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Departments of Gastroenterology and Clinical Laboratory, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, 200001, China